VECO
Veeco Instruments Inc. NASDAQ Listed Nov 29, 1994$57.72
Mkt Cap $3.5B
52w Low $18.31
83.6% of range
52w High $65.43
50d MA $38.45
200d MA $30.96
P/E (TTM)
83.8x
EV/EBITDA
34.6x
P/B
3.4x
Debt/Equity
0.3x
ROE
4.0%
P/FCF
37.1x
RSI (14)
—
ATR (14)
—
Beta
1.10
50d MA
$38.45
200d MA
$30.96
Avg Volume
1.2M
Veeco Instruments Inc., together with its subsidiaries, develops, manufactures, sells, and supports semiconductor and thin film process equipment primarily to make electronic devices worldwide. The company offers laser annealing, ion beam deposition and etch, metal organic chemical vapor deposition, single wafer wet processing and surface preparation, molecular beam epitaxy, and atomic layer deposition and other deposition systems, as well as packaging lithography equipment. Its process equipment systems are used in the production of a range of microelectronic components, including logic, dynamic random-access memory, photonics devices, power electronics, radio frequency filters and amplifiers, magnetic heads for hard disk drives, and other semiconductor devices. In addition, the company markets and sells its products to integrated device manufacturers and foundries; outsourced semiconductor assembly and test, hard disk drive, and photonics manufacturers; and research centers and universities. Veeco Instruments Inc. was founded in 1945 and is headquartered in Plainview, New York.
1 Terminal Drive · Plainview, NY 11803 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | AMC | 0.20 | 0.14 | -30.0% | 49.54 | +25.7% | +25.2% | -6.9% | — | — | — | — |
| Feb 25, 2026 | AMC | 0.25 | 0.24 | -4.0% | 28.46 | +7.2% | +7.8% | -0.4% | +6.9% | -0.6% | -0.3% | — |
| Nov 5, 2025 | AMC | 0.28 | 0.36 | +28.6% | 29.45 | +0.2% | -1.0% | +4.3% | +2.1% | -1.6% | -0.8% | — |
| Aug 6, 2025 | AMC | 0.22 | 0.36 | +63.6% | 19.94 | +14.0% | +15.0% | +2.9% | +1.1% | +1.8% | +2.6% | — |
| May 7, 2025 | AMC | 0.32 | 0.37 | +15.6% | 18.89 | -3.1% | +5.3% | -3.5% | +9.6% | +0.7% | +0.8% | — |
| Feb 12, 2025 | AMC | 0.40 | 0.41 | +2.5% | 23.65 | +0.2% | +2.6% | +1.6% | +1.3% | -0.4% | +1.5% | — |
| Nov 6, 2024 | AMC | 0.45 | 0.46 | +2.2% | 30.10 | +1.5% | -3.4% | -1.4% | -2.0% | -0.5% | -2.4% | — |
| Aug 6, 2024 | AMC | 0.44 | 0.42 | -4.5% | 35.12 | -6.6% | -6.3% | +8.9% | +1.8% | +0.9% | -0.1% | — |
| May 7, 2024 | AMC | 0.41 | 0.45 | +9.8% | 37.49 | +3.2% | +4.8% | -3.1% | -0.2% | -0.8% | +3.2% | — |
| Feb 14, 2024 | AMC | 0.43 | 0.51 | +18.6% | 35.30 | -1.1% | +0.5% | +0.0% | -4.7% | +0.2% | +3.5% | — |
| Nov 6, 2023 | AMC | 0.37 | 0.53 | +43.2% | 24.86 | +9.1% | +8.6% | -2.0% | +1.4% | +3.6% | -0.5% | — |
| Aug 7, 2023 | AMC | 0.30 | 0.36 | +20.0% | 28.19 | +2.8% | +6.8% | +1.8% | -0.9% | -1.3% | +1.6% | — |
| May 8, 2023 | AMC | 0.20 | 0.30 | +50.0% | 19.25 | +1.4% | +5.2% | +2.7% | -0.5% | +0.3% | +4.1% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26 | Citigroup | Maintains | Buy → Buy | — | $28.46 | $30.50 | +7.2% | +7.8% | -0.4% | +6.9% | -0.6% | -0.3% |
| Nov 12 | Citigroup | Maintains | Buy → Buy | — | $30.57 | $30.92 | +1.1% | -0.8% | -3.4% | -0.4% | -2.2% | -4.0% |
| Oct 3 | Needham | Downgrade | Buy → Hold | — | $33.10 | $32.65 | -1.4% | -4.5% | -2.4% | -4.1% | +0.5% | -0.8% |
| Aug 7 | Needham | Maintains | Buy → Buy | — | $19.94 | $22.74 | +14.0% | +15.0% | +2.9% | +1.1% | +1.8% | +2.6% |
| Aug 7 | Benchmark | Maintains | Buy → Buy | — | $19.94 | $22.74 | +14.0% | +15.0% | +2.9% | +1.1% | +1.8% | +2.6% |
| May 9 | Goldman Sachs | Maintains | Neutral → Neutral | — | $19.90 | $19.92 | +0.1% | -3.5% | +9.6% | +0.7% | +0.8% | -0.5% |
| May 8 | Barclays | Maintains | Equal Weight → Equal Weight | — | $18.89 | $18.31 | -3.1% | +5.3% | -3.5% | +9.6% | +0.7% | +0.8% |
| Apr 22 | Barclays | Maintains | Equal Weight → Equal Weight | — | $17.61 | $17.78 | +1.0% | +1.1% | +2.2% | +5.7% | +0.7% | -1.3% |
| Feb 13 | Benchmark | Maintains | Buy → Buy | — | $23.65 | $23.70 | +0.2% | +2.6% | +1.6% | +1.3% | -0.4% | +1.5% |
| Feb 13 | Citigroup | Maintains | Buy → Buy | — | $23.65 | $23.70 | +0.2% | +2.6% | +1.6% | +1.3% | -0.4% | +1.5% |
| Feb 13 | Needham | Maintains | Buy → Buy | — | $23.65 | $23.70 | +0.2% | +2.6% | +1.6% | +1.3% | -0.4% | +1.5% |
| Feb 13 | Barclays | Maintains | Equal Weight → Equal Weight | — | $23.65 | $23.70 | +0.2% | +2.6% | +1.6% | +1.3% | -0.4% | +1.5% |
| Feb 7 | Oppenheimer | Maintains | Outperform → Outperform | — | $25.25 | $25.33 | +0.3% | -3.4% | +1.0% | -3.8% | -0.1% | +2.6% |
| Jan 6 | Citigroup | Upgrade | Neutral → Buy | — | $27.16 | $28.55 | +5.1% | +5.7% | -0.4% | -1.6% | -5.2% | -2.1% |
| Nov 7 | Benchmark | Maintains | Buy → Buy | — | $30.10 | $30.54 | +1.5% | -3.4% | -1.4% | -2.0% | -0.5% | -2.4% |
| Nov 7 | Goldman Sachs | Maintains | Neutral → Neutral | — | $30.10 | $30.54 | +1.5% | -3.4% | -1.4% | -2.0% | -0.5% | -2.4% |
| Nov 7 | Oppenheimer | Maintains | Outperform → Outperform | — | $30.10 | $30.54 | +1.5% | -3.4% | -1.4% | -2.0% | -0.5% | -2.4% |
| Aug 8 | Goldman Sachs | Maintains | Neutral → Neutral | — | $32.92 | $34.30 | +4.2% | +8.9% | +1.8% | +0.9% | -0.1% | -1.9% |
| Aug 7 | Benchmark | Maintains | Buy → Buy | — | $35.12 | $32.80 | -6.6% | -6.3% | +8.9% | +1.8% | +0.9% | -0.1% |
| Aug 7 | Northland Capital Markets | Maintains | Outperform → Outperform | — | $35.12 | $32.80 | -6.6% | -6.3% | +8.9% | +1.8% | +0.9% | -0.1% |
| Aug 7 | Needham | Maintains | Buy → Buy | — | $35.12 | $32.80 | -6.6% | -6.3% | +8.9% | +1.8% | +0.9% | -0.1% |
| Jul 15 | Citigroup | Downgrade | Buy → Neutral | — | $47.19 | $46.70 | -1.0% | -1.0% | +0.4% | -8.8% | -3.4% | -2.8% |
| Jun 27 | Oppenheimer | Maintains | Outperform → Outperform | — | $45.83 | $46.41 | +1.3% | +2.0% | -0.1% | +0.4% | +0.6% | +0.4% |
| May 15 | Oppenheimer | Maintains | Outperform → Outperform | — | $38.93 | $39.53 | +1.5% | +4.5% | -1.4% | -0.4% | +1.6% | -0.1% |
| May 9 | Goldman Sachs | Maintains | Neutral → Neutral | — | $39.29 | $39.27 | -0.1% | -3.1% | -0.2% | -0.8% | +3.2% | +4.5% |
| May 8 | Needham | Maintains | Buy → Buy | — | $37.49 | $38.68 | +3.2% | +4.8% | -3.1% | -0.2% | -0.8% | +3.2% |
| May 8 | Barclays | Maintains | Equal Weight → Equal Weight | — | $37.49 | $38.68 | +3.2% | +4.8% | -3.1% | -0.2% | -0.8% | +3.2% |
| Feb 21 | Citigroup | Maintains | Buy → Buy | — | $33.79 | $33.72 | -0.2% | +0.2% | +3.5% | +0.1% | +1.7% | -0.6% |
| Feb 15 | Goldman Sachs | Maintains | Neutral → Neutral | — | $35.30 | $34.92 | -1.1% | +0.5% | +0.0% | -4.7% | +0.2% | +3.5% |
| Feb 15 | Benchmark | Maintains | Buy → Buy | — | $35.30 | $34.92 | -1.1% | +0.5% | +0.0% | -4.7% | +0.2% | +3.5% |
| Jan 18 | Goldman Sachs | Maintains | Neutral → Neutral | — | $30.09 | $31.21 | +3.7% | +5.1% | +2.9% | +2.6% | -1.3% | +1.1% |
| Jan 16 | Barclays | Maintains | Equal Weight → Equal Weight | — | $28.35 | $28.52 | +0.6% | +5.1% | +1.0% | +5.1% | +2.9% | +2.6% |
| Nov 7 | Benchmark | Maintains | Buy → Buy | — | $24.86 | $27.12 | +9.1% | +8.6% | -2.0% | +1.4% | +3.6% | -0.5% |
| Sep 15 | Benchmark | Maintains | Buy → Buy | — | $28.37 | $28.00 | -1.3% | -6.1% | +0.9% | -0.0% | -1.2% | -1.1% |
| Aug 9 | Goldman Sachs | Maintains | Neutral → Neutral | — | $30.12 | $29.93 | -0.6% | +1.8% | -0.9% | -1.3% | +1.6% | -2.5% |
| Aug 8 | Benchmark | Maintains | Buy → Buy | — | $28.19 | $28.99 | +2.8% | +6.8% | +1.8% | -0.9% | -1.3% | +1.6% |
| Aug 8 | Barclays | Maintains | Equal Weight → Equal Weight | — | $28.19 | $28.99 | +2.8% | +6.8% | +1.8% | -0.9% | -1.3% | +1.6% |
| Aug 8 | Goldman Sachs | Maintains | Neutral → Neutral | — | $28.19 | $28.99 | +2.8% | +6.8% | +1.8% | -0.9% | -1.3% | +1.6% |
| Aug 3 | Oppenheimer | Maintains | Outperform → Outperform | — | $28.48 | $28.48 | +0.0% | +1.3% | -2.2% | -0.1% | +6.8% | +1.8% |
| Jul 20 | Barclays | Maintains | Equal Weight → Equal Weight | — | $26.54 | $26.16 | -1.4% | -3.0% | +2.5% | -0.3% | +1.0% | -0.4% |
| May 26 | Benchmark | Maintains | Buy → Buy | — | $23.30 | $23.53 | +1.0% | +5.5% | -0.3% | -0.4% | +1.8% | +0.9% |
| May 18 | Oppenheimer | Maintains | Outperform → Outperform | — | $22.12 | $22.34 | +1.0% | +3.5% | -0.3% | +0.8% | -1.2% | -1.0% |
| May 9 | Benchmark | Maintains | Buy → Buy | — | $19.25 | $19.51 | +1.4% | +5.2% | +2.7% | -0.5% | +0.3% | +4.1% |
| May 9 | Northland Capital Markets | Maintains | Outperform → Outperform | — | $19.25 | $19.51 | +1.4% | +5.2% | +2.7% | -0.5% | +0.3% | +4.1% |
| Jan 23 | Barclays | Downgrade | Overweight → Equal Weight | — | $20.12 | $19.27 | -4.2% | +0.2% | -0.9% | +0.3% | +1.3% | -1.3% |
| Jan 13 | Benchmark | Maintains | Buy → Buy | — | $20.67 | $20.57 | -0.5% | -1.6% | -0.5% | -0.6% | -1.6% | +1.7% |
| Nov 9 | Goldman Sachs | Maintains | Neutral → Neutral | — | $18.32 | $18.03 | -1.6% | -0.9% | +7.9% | +0.7% | -1.4% | +1.4% |
| Nov 8 | Barclays | Maintains | Overweight → Overweight | — | $18.00 | $17.90 | -0.6% | +1.8% | -0.9% | +7.9% | +0.7% | -1.4% |
| Nov 8 | Oppenheimer | Maintains | Outperform → Outperform | — | $18.00 | $17.90 | -0.6% | +1.8% | -0.9% | +7.9% | +0.7% | -1.4% |
| Nov 1 | Oppenheimer | Maintains | Outperform → Outperform | — | $18.23 | $18.53 | +1.6% | +0.0% | -2.6% | -2.3% | +3.7% | +0.0% |
No insider trades available.
8-K
Veeco Instruments Inc -- 8-K Filing
Veeco Instruments reported its Q4 and full-year 2025 financial results, providing investors with updated performance metrics and guidance for assessing the company's operational trajectory going forward.
Feb 25
8-K
Axcelis Technologies Inc -- 8-K Filing
Axcelis Technologies held a special shareholder meeting with a quorum present to vote on proposals, though specific outcomes and deal details were not provided in this summary.
Feb 6
8-K
Veeco Instruments Inc -- 8-K Filing
I need more complete information to write an accurate summary. The filing summary appears incomplete—it mentions a Special Meeting and proposals but doesn't specify the outcome or details needed to assess investor impact.
Could you provide the complete summary or key details about what was voted on and the results?
Feb 6
8-K · 8.01
!! High
Veeco Instruments Inc -- 8-K 8.01: Material Event / Announcement
Veeco's merger with Axcelis has cleared UK national security review with a no-further-action letter, and both companies determined Swedish investment screening filings are unnecessary, removing regulatory hurdles toward deal completion.
Feb 2
8-K
Axcelis Technologies Inc -- 8-K Filing
Axcelis Technologies and Veeco Instruments have scheduled stockholder votes for February 6, 2026, to approve their merger, with completion contingent on both companies' shareholder approval.
Feb 2
Data updated apr 27, 2026 7:27am
· Source: massive.com